TFX (STOCKS)
Teleflex Incorporated
$104.540000
-2.410000 (-2.25%)
Prev close: $106.950000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Stuart Allen Randle
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,619.20M
- Employees
- 14,100
- P/E (TTM)
- -14.21
- P/B (TTM)
- 1.24
- Dividend Yield
- 127.16%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
12
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$3.67 | $3.42 | +0.2534 | +7.42% |
|
Jun 2025 (Q2)
|
$3.73 | $3.40 | +0.3341 | +9.84% |
|
Mar 2025 (Q1)
|
$2.91 | $2.95 | -0.0358 | -1.22% |
|
Dec 2024 (Q4)
|
$3.89 | $3.90 | -0.0103 | -0.26% |
Financial Statements
| Revenues | $3.19B |
| Benefits Costs and Expenses | $3.51B |
| Cost Of Revenue | $1.48B |
| Costs And Expenses | $3.51B |
| Gross Profit | $1.71B |
| Operating Expenses | $1.95B |
| Selling, General, and Administrative Expenses | $974.11M |
| Depreciation and Amortization | $282.76M |
| Research and Development | $176.71M |
| Other Operating Expenses | $314.10M |
| Operating Income/Loss | -$238.40M |
| Income/Loss From Continuing Operations After Tax | -$327.85M |
| Income/Loss From Continuing Operations Before Tax | -$321.15M |
| Income/Loss From Discontinued Operations Net Of Tax | -$115.00K |
| Income Tax Expense/Benefit | $6.70M |
| Income Tax Expense/Benefit, Deferred | -$108.64M |
| Net Income/Loss | -$327.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$327.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$327.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.31 |
| Diluted Earnings Per Share | -$7.31 |
| Basic Average Shares | 44,597,000 |
| Diluted Average Shares | 44,593,000 |
| Assets | $7.87B |
| Current Assets | $1.99B |
| Inventory | $802.47M |
| Other Current Assets | $1.18B |
| Noncurrent Assets | $5.89B |
| Fixed Assets | $700.59M |
| Intangible Assets | $2.41B |
| Other Non-current Assets | $2.77B |
| Liabilities | $4.05B |
| Current Liabilities | $773.03M |
| Accounts Payable | $165.91M |
| Wages | $167.74M |
| Other Current Liabilities | $439.39M |
| Noncurrent Liabilities | $3.28B |
| Long-term Debt | $2.67B |
| Other Non-current Liabilities | $605.54M |
| Equity | $3.82B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.82B |
| Liabilities And Equity | $7.87B |
| Net Cash Flow From Operating Activities | $390.94M |
| Net Cash Flow From Operating Activities, Continuing | $391.61M |
| Net Cash Flow From Operating Activities, Discontinued | -$667.00K |
| Net Cash Flow From Investing Activities | -$849.87M |
| Net Cash Flow From Investing Activities, Continuing | -$849.87M |
| Net Cash Flow From Financing Activities | $554.03M |
| Net Cash Flow From Financing Activities, Continuing | $554.03M |
| Exchange Gains/Losses | $8.44M |
| Net Cash Flow | $103.55M |
| Net Cash Flow, Continuing | $95.77M |
| Net Cash Flow, Discontinued | -$667.00K |
| Comprehensive Income/Loss | -$333.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$333.40M |
| Other Comprehensive Income/Loss | -$5.44M |